Skip to main content

Advertisement

SpringerLink
Log in

JAK Inhibition with Baricitinib for Severe CVID-Related Enteropathy: a Case Report

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data Availability

Not applicable.

References

  1. Strohmeier V, Andrieux G, Unger S, Pascual-Reguant A, Klocperk A, Seidl M, et al. Interferon-driven immune dysregulation in common variable immunodeficiency-associated villous atrophy and norovirus infection. J Clin Immunol. 2023;43(2):371–90.

  2. van den Hoogen LL, van Roon JAG, Mertens JS, Wienke J, Lopes AP, de Jager W, et al. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2018;77(12):1810–4.

    Article  PubMed  Google Scholar 

  3. Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, et al. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease. N Engl J Med. 2021;385(3):228–38.

    Article  CAS  PubMed  Google Scholar 

  4. Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131(3):748–56.

    Article  CAS  PubMed  Google Scholar 

  5. Jorgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, et al. A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency. Am J Gastroenterol. 2016;111(10):1467–75.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

    Amir Abdelmoumen & Helen Leavis

  2. Department of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

    Amir Abdelmoumen & Joris van Montfrans

  3. Division Laboratories, Pharmacy and Biomedical Genetics, Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

    Amir Abdelmoumen & Femke van Wijk

  4. University Medical Center Utrecht, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands

    Amir Abdelmoumen, Joris van Montfrans, Femke van Wijk & Helen Leavis

Authors
  1. Amir Abdelmoumen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joris van Montfrans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Femke van Wijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Helen Leavis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The manuscript was written, and figures were made by A.A. H.L. and J.M. were involved in the clinical care of the patient. H.L., J.M., and F.W. commented on previous versions of the manuscript. All the authors read and approved the final manuscript.

Corresponding authors

Correspondence to Amir Abdelmoumen or Helen Leavis.

Ethics declarations

Ethical Approval

Not applicable.

Consent to Participate

Informed consent was obtained from the patient presented in this case report.

Consent for Publication

Informed consent to publish was obtained from the patient presented in this case report.

Conflict of Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 165 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelmoumen, A., van Montfrans, J., van Wijk, F. et al. JAK Inhibition with Baricitinib for Severe CVID-Related Enteropathy: a Case Report. J Clin Immunol 43, 1766–1769 (2023). https://doi.org/10.1007/s10875-023-01569-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-023-01569-6

Search

Navigation